AllianceBernstein’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $236M | Sell |
672,672
-113,244
| -14% | -$37.2M | 0.08% | 193 |
|
|
2025
Q4 | $276M | Sell |
785,916
-127,135
| -14% | -$43M | 0.09% | 177 |
|
|
2025
Q3 | $295M | Sell |
913,051
-482,748
| -35% | -$150M | 0.09% | 169 |
|
|
2025
Q2 | $543M | Sell |
1,395,799
-496,069
| -26% | -$200M | 0.18% | 101 |
|
|
2025
Q1 | $823M | Sell |
1,891,868
-213,889
| -10% | -$85.9M | 0.3% | 62 |
|
|
2024
Q4 | $777M | Sell |
2,105,757
-400,813
| -16% | -$168M | 0.26% | 70 |
|
|
2024
Q3 | $1.3B | Sell |
2,506,570
-249,394
| -9% | -$133M | 0.44% | 43 |
|
|
2024
Q2 | $1.49B | Sell |
2,755,964
-244,790
| -8% | -$129M | 0.52% | 33 |
|
|
2024
Q1 | $1.56B | Sell |
3,000,754
-305,243
| -9% | -$152M | 0.55% | 31 |
|
|
2023
Q4 | $1.56B | Sell |
3,305,997
-107,659
| -3% | -$49.8M | 0.6% | 28 |
|
|
2023
Q3 | $1.49B | Buy |
3,413,656
+198,993
| +6% | +$90.3M | 0.63% | 26 |
|
|
2023
Q2 | $1.43B | Buy |
3,214,663
+372,937
| +13% | +$172M | 0.58% | 30 |
|
|
2023
Q1 | $1.31B | Buy |
2,841,726
+334,912
| +13% | +$159M | 0.56% | 30 |
|
|
2022
Q4 | $1.29B | Sell |
2,506,814
-122,264
| -5% | -$62.1M | 0.58% | 26 |
|
|
2022
Q3 | $1.19B | Sell |
2,629,078
-75,736
| -3% | -$36.2M | 0.58% | 24 |
|
|
2022
Q2 | $1.31B | Sell |
2,704,814
-267,322
| -9% | -$132M | 0.6% | 26 |
|
|
2022
Q1 | $1.46B | Sell |
2,972,136
-682,360
| -19% | -$312M | 0.56% | 24 |
|
|
2021
Q4 | $1.69B | Sell |
3,654,496
-280,284
| -7% | -$118M | 0.6% | 24 |
|
|
2021
Q3 | $1.47B | Buy |
3,934,780
+535,038
| +16% | +$203M | 0.58% | 23 |
|
|
2021
Q2 | $1.3B | Sell |
3,399,742
-298,002
| -8% | -$114M | 0.52% | 27 |
|
|
2021
Q1 | $1.33B | Buy |
3,697,744
+106,902
| +3% | +$34.4M | 0.58% | 25 |
|
|
2020
Q4 | $1.15B | Sell |
3,590,842
-283,274
| -7% | -$86.9M | 0.54% | 31 |
|
|
2020
Q3 | $1.04B | Buy |
3,874,116
+438,300
| +13% | +$118M | 0.56% | 31 |
|
|
2020
Q2 | $904M | Buy |
3,435,816
+406,274
| +13% | +$108M | 0.53% | 31 |
|
|
2020
Q1 | $688M | Sell |
3,029,542
-74,294
| -2% | -$20.2M | 0.49% | 40 |
|
|
2019
Q4 | $937M | Buy |
3,103,836
+64,509
| +2% | +$17.8M | 0.53% | 34 |
|
|
2019
Q3 | $730M | Sell |
3,039,327
-59,295
| -2% | -$16.2M | 0.45% | 44 |
|
|
2019
Q2 | $874M | Buy |
3,098,622
+309,234
| +11% | +$84.5M | 0.54% | 37 |
|
|
2019
Q1 | $800M | Sell |
2,789,388
-79,121
| -3% | -$22.9M | 0.52% | 38 |
|
|
2018
Q4 | $753M | Sell |
2,868,509
-90,084
| -3% | -$24.8M | 0.56% | 36 |
|
|
2018
Q3 | $811M | Buy |
2,958,593
+7,671
| +0.3% | +$1.99M | 0.53% | 38 |
|
|
2018
Q2 | $702M | Buy |
2,950,922
+252,518
| +9% | +$58.5M | 0.49% | 44 |
|
|
2018
Q1 | $593M | Buy |
2,698,404
+781,858
| +41% | +$184M | 0.43% | 55 |
|
|
2017
Q4 | $431M | Buy |
1,916,546
+68,295
| +4% | +$14.5M | 0.31% | 80 |
|
|
2017
Q3 | $351M | Buy |
1,848,251
+70,273
| +4% | +$13.4M | 0.26% | 97 |
|
|
2017
Q2 | $334M | Buy |
1,777,978
+55,597
| +3% | +$9.99M | 0.26% | 90 |
|
|
2017
Q1 | $285M | Buy |
1,722,381
+191,741
| +13% | +$30.5M | 0.23% | 102 |
|
|
2016
Q4 | $220M | Buy |
1,530,640
+76,371
| +5% | +$10.2M | 0.18% | 119 |
|
|
2016
Q3 | $182M | Sell |
1,454,269
-1,841,469
| -56% | -$238M | 0.15% | 138 |
|
|
2016
Q2 | $433M | Buy |
3,295,738
+602,123
| +22% | +$82.4M | 0.37% | 60 |
|
|
2016
Q1 | $374M | Sell |
2,693,615
-268,654
| -9% | -$35.9M | 0.32% | 72 |
|
|
2015
Q4 | $413M | Sell |
2,962,269
-595,707
| -17% | -$82.1M | 0.35% | 60 |
|
|
2015
Q3 | $498M | Sell |
3,557,976
-1,582,352
| -31% | -$238M | 0.43% | 50 |
|
|
2015
Q2 | $844M | Sell |
5,140,328
-412,547
| -7% | -$65.9M | 0.7% | 22 |
|
|
2015
Q1 | $857M | Sell |
5,552,875
-198,754
| -3% | -$28.3M | 0.7% | 22 |
|
|
2014
Q4 | $723M | Buy |
5,751,629
+968,501
| +20% | +$120M | 0.6% | 26 |
|
|
2014
Q3 | $572M | Buy |
4,783,128
+3,387,198
| +243% | +$389M | 0.48% | 38 |
|
|
2014
Q2 | $150M | Buy |
1,395,930
+312,212
| +29% | +$32.2M | 0.13% | 182 |
|
|
2014
Q1 | $108M | Sell |
1,083,718
-1,757,379
| -62% | -$159M | 0.09% | 252 |
|
|
2013
Q4 | $262M | Sell |
2,841,097
-5,460,994
| -66% | -$485M | 0.23% | 101 |
|
|
2013
Q3 | $694M | Sell |
8,302,091
-221,974
| -3% | -$19M | 0.69% | 21 |
|
|
2013
Q2 | $698M | Buy |
+8,524,065
| New | +$638M | 0.74% | 17 |
|
Other funds holding ELV
VCM
VPM
AllianceBernstein's ELV Position: Q1 2026 in Review
AllianceBernstein reduced its Elevance Health (ELV) stake by 14% in Q1 2026, selling an estimated $37.2M and leaving 672,672 shares worth $236M. The position accounts for 0.08% of the portfolio, ranked #193.
AllianceBernstein first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.69B in Q4 2021. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- AllianceBernstein held 672,672 shares of Elevance Health worth $236M as of Q1 2026.
- AllianceBernstein sold 113,244 Elevance Health shares in Q1 2026, an estimated $37.2M.
- Elevance Health made up 0.08% of AllianceBernstein's portfolio in Q1 2026, its #193 holding.
- AllianceBernstein first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- AllianceBernstein's Elevance Health position peaked at $1.69B in Q4 2021.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.